Maria Jose Baeza Robba, second-year Ph.D. student, and Nicholas Metheny, assistant professor, joined forces to tackle grad school, research firsts, and COVID-19 concerns in the sexual and gender minority community.
Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results
OVERVIEW
The Company reported a net loss and total comprehensive loss of $2,554,000 and $5,268,000 for the three and nine-month periods ended April 30, 2021. For the three and nine-month periods ended April 30, 2020, net loss and total comprehensive loss totalled $2,489,000 and $6,896,000, respectively. The net loss and total comprehensive loss for the three-month period ending April 30, 2021, includes a net loss of $nil (2020 - $198,000) and for the nine-month period ending April 30, 2021 a gain of $1,536,000 (2020 - loss of $465,000) from discontinued operations. The Company lost control of its subsidiary in Poland during the three-month period ending October 31, 2020 though continued to exert significant influence until December 22, 2020 when the Company disposed of its remaining interest for gross proceeds of $2,308,000.
Army medic, nurse returns to Tampa with renewed dedication to fighting COVID
Alexandra Houston
and last updated 2021-05-26 07:56:58-04
TAMPA, Fla. â Last year nurses from around the country were deployed to hospitals in New York and New Jersey to help care for patients with COVID-19.
Those nurses may have returned home, but for many of them, the fight against COVID continues every day.
Before Alexandra Houston was wearing scrubs for the Moffit Cancer Center, she was wearing fatigues for the United States Military, serving in Iraq as an army medic.
Alexandra Houston
âIt was intense, it changed you as a person I think, and I was young, so I had to grow up pretty fast,â said Houston.